Gangjee A[au] - Search Results

Year	Number of Results
1976	1
1978	1
1982	1
1991	1
1992	1
1993	4
1994	1
1995	5
1996	3
1997	7
1998	5
1999	2
2000	2
2001	2
2002	4
2003	5
2004	6
2005	5
2006	3
2007	5
2008	8
2009	5
2010	10
2011	6
2012	9
2013	13
2014	4
2015	6
2016	8
2017	8
2018	8
2019	5
2020	4
2021	6
2022	2

1

AG488 as a therapy against gliomas.

Ziegler J, Bastian A, Lerner M, Bailey-Downs L, Saunders D, Smith N, Sutton J, Battiste JD, Ihnat MA, Gangjee A, Towner RA. Ziegler J, et al. Among authors: gangjee a. Oncotarget. 2017 May 30;8(42):71833-71844. doi: 10.18632/oncotarget.18284. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069750 Free PMC article.

2

Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.

Dekhne AS, Hou Z, Gangjee A, Matherly LH. Dekhne AS, et al. Among authors: gangjee a. Mol Cancer Ther. 2020 Nov;19(11):2245-2255. doi: 10.1158/1535-7163.MCT-20-0423. Epub 2020 Sep 2. Mol Cancer Ther. 2020. PMID: 32879053 Free PMC article. Review.

3

Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer.

Wallace-Povirk A, Hou Z, Nayeen MJ, Gangjee A, Matherly LH. Wallace-Povirk A, et al. Among authors: gangjee a. Cancers (Basel). 2021 Dec 31;14(1):191. doi: 10.3390/cancers14010191. Cancers (Basel). 2021. PMID: 35008360 Free PMC article. Review.

4

Folate transporter dynamics and therapy with classic and tumor-targeted antifolates.

O'Connor C, Wallace-Povirk A, Ning C, Frühauf J, Tong N, Gangjee A, Matherly LH, Hou Z. O'Connor C, et al. Among authors: gangjee a. Sci Rep. 2021 Mar 18;11(1):6389. doi: 10.1038/s41598-021-85818-x. Sci Rep. 2021. PMID: 33737637 Free PMC article.

5

Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer.

Choudhary S, Doshi A, Luckett-Chastain L, Ihnat M, Hamel E, Mooberry SL, Gangjee A. Choudhary S, et al. Among authors: gangjee a. Bioorg Med Chem. 2021 Apr 1;35:116061. doi: 10.1016/j.bmc.2021.116061. Epub 2021 Feb 12. Bioorg Med Chem. 2021. PMID: 33647840 Free PMC article.

6

Antifolates -- past, present and future.

Gangjee A, Jain HD. Gangjee A, et al. Curr Med Chem Anticancer Agents. 2004 Sep;4(5):405-10. doi: 10.2174/1568011043352803. Curr Med Chem Anticancer Agents. 2004. PMID: 15379693 Review.

7

2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance.

Gangjee A, Namjoshi OA, Keller SN, Smith CD. Gangjee A, et al. Bioorg Med Chem. 2011 Jul 15;19(14):4355-65. doi: 10.1016/j.bmc.2011.05.030. Epub 2011 May 23. Bioorg Med Chem. 2011. PMID: 21680190 Free PMC article.

8

Dihydrofolate reductase as a target for chemotherapy in parasites.

Gangjee A, Kurup S, Namjoshi O. Gangjee A, et al. Curr Pharm Des. 2007;13(6):609-39. doi: 10.2174/138161207780162827. Curr Pharm Des. 2007. PMID: 17346178 Review.

9

The 3-D conformational shape of N-naphthyl-cyclopenta[d]pyrimidines affects their potency as microtubule targeting agents and their antitumor activity.

Xiang W, Quadery TM, Hamel E, Luckett-Chastain LR, Ihnat MA, Mooberry SL, Gangjee A. Xiang W, et al. Among authors: gangjee a. Bioorg Med Chem. 2021 Jan 1;29:115887. doi: 10.1016/j.bmc.2020.115887. Epub 2020 Nov 24. Bioorg Med Chem. 2021. PMID: 33310545 Free PMC article.

10

Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism.

Dekhne AS, Ning C, Nayeen MJ, Shah K, Kalpage H, Frühauf J, Wallace-Povirk A, O'Connor C, Hou Z, Kim S, Hüttemann M, Gangjee A, Matherly LH. Dekhne AS, et al. Among authors: gangjee a. Mol Pharmacol. 2020 Jan;97(1):9-22. doi: 10.1124/mol.119.117937. Epub 2019 Nov 9. Mol Pharmacol. 2020. PMID: 31707355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results